Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JE.1.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.83ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.83NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-17121.6US
GK.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.24.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.24.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.24.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.8.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.8.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.8.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.8.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GE.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GE.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GE.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
GA.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
GA.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.3.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.3.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.3.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.3.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.13.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.13.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.20.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used